Breeze Acquisition Corp. II — Form 10-Q Summary
Business context and reporting period
Unaudited results for the quarter and six months ended June 30, 2026. Breeze is a Cayman Islands blank-check company incorporated in August 2025 to pursue a business combination; it had not begun operations, generated no operating revenue, and had selected no target. Its IPO closed May 14, 2026, with a partial over-allotment exercise on May 15. The filing reports no substantive target discussions.
Financial position and results
| Metric | Amount |
|---|---|
| Q2 operating and formation costs | $248,218 |
| Q2 net income | $398,121 |
| Six-month operating and formation costs | $386,424 |
| Six-month net income | $259,915 |
| Q2 and six-month basic and diluted EPS | $0.03 per redeemable and non-redeemable share |
| Cash outside trust at June 30 | $130,963 |
| Cash in trust at June 30 | $140,974,649 |
| Total assets / total liabilities | $141,497,960 / $179,538 |
| Working capital surplus | $343,773 |
| Six-month cash flow | $656,165 used in operations; $140,350,000 used in investing; $141,137,128 provided by financing |
| Related-party promissory note | $0 outstanding at June 30; repaid at IPO closing |
Income primarily reflects $624,649 of trust interest for the six-month period and a $21,000 gain from the change in fair value of the over-allotment liability, offset by operating costs. The company has no operating revenue, so conventional operating margins are not meaningful. No prior-year comparable operating period is presented; the company was formed in August 2025 and completed its IPO in May 2026. The balance sheet compares with December 31, 2025.
Material changes, outlook, and risks
- The IPO and partial over-allotment raised $140 million in public-unit gross proceeds; the sponsor purchased $4.7 million of private units. $140.35 million was deposited into the trust account.
- Despite a reported working capital surplus, management says resources outside the trust are insufficient to sustain operations for one year and identifies substantial doubt about the company’s ability to continue as a going concern. Trust funds are generally reserved for a business combination or redemption, not ordinary working capital.
- The company must complete a business combination by May 14, 2027, unless shareholders approve an extension. Failure to do so requires liquidation; there is no assurance a transaction will be completed.
- The company reports a material weakness in controls over reviewing vendor service contracts. It says an obligation that did not exist was recorded and cash was disbursed; remediation procedures are being implemented. Management concluded disclosure controls were not effective as of June 30.
- The company recorded $1.15 million due from the sponsor as a contra-equity item, describing it as proceeds from private units not received by the company that were paid to a third party to satisfy sponsor obligations. Recovery and accounting are important to assess.
- An advisory-services agreement calls for $800,000 at IPO closing and four quarterly payments of $350,000 each, totaling $2.2 million, plus transfer of founder shares with a stated target value of $1 million. The filing does not clearly establish the remaining unpaid cash commitment at June 30.
- Nasdaq notified the company on August 20, 2026 that late quarterly reports put it out of compliance with its filing-timeliness rule. The March 31 report was filed September 23; this June 30 report is signed October 16. The filing cites geopolitical, market, liquidity, cybersecurity, and transaction-execution risks. No legal proceedings or material changes to prospectus risk factors were reported.
Most important facts for investors to verify
- Current unrestricted cash, near-term obligations, and the timing and amount of remaining advisor payments; distinguish these from restricted trust assets.
- Status and collectability of the $1.15 million due from the sponsor, and whether it is connected to the vendor-contract control failure and cash disbursement.
- Progress on control remediation and whether the late-filing Nasdaq deficiency has been resolved.
- Any target discussions or transaction developments, and the feasibility of completing a business combination by May 14, 2027.
- Reconcile reported income and cash-flow figures, share counts, and the advisory and sponsor-related disclosures against the full financial statements and subsequent filings.